\-\ Texto\\:\\ \ \(0\)\
\-\ evidence\\ of\\ hepatomegaly\\ on\\ physical\\ examination\\ but\\ no\\ palpable\\ focal\\ abdominal\\ mass\\.\\ \\ labs\\ notable\\ for\\ nonspecifically\\ and\\ mildly\\ elevated\\ lfts\\.\ \(0\)\
\-\ enlarged\\ liver\\ with\\ nodular\\ and\\ heterogeneous\\ pattern\\ of\\ enhancement\\.\\ \\ periportal\\ and\\ retroperitoneal\\ lymphadenopathy\\.\\ \\ these\\ findings\\ are\\ consistent\\ with\\ abdominal\\ sarcoid\\ in\\ this\\ clinical\\ setting\\.\ \(0\)\
\-\ sarcoidosis\\,\\ abdomen\\ and\\ liver\ \(0\)\
\-\ metastatic\\ disease\\ \\(colon\\,\\ stonach\\,\\ pancreas\\,\\ breast\\,\\ lung\\)\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ other\\ infiltrative\\ liver\\ processes\ \(0\)\
\-\ patient\\ with\\ history\\ of\\ thoracic\\ sarcoid\\ presenting\\ with\\ increasing\\ lfts\\ and\\ pruritis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lfts\\:\\ 0\\.33861277592824546\ \(0\)\
\-\ liver\\:\\ 0\\.30298517704365147\ \(0\)\
\-\ sarcoid\\:\\ 0\\.27460270396049924\ \(0\)\
\-\ stonach\\:\\ 0\\.23412911673335218\ \(0\)\
\-\ nonspecifically\\:\\ 0\\.22372287028739626\ \(0\)\
\-\ periportal\\:\\ 0\\.198549925133457\ \(0\)\
\-\ pruritis\\:\\ 0\\.19037682234018383\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.18241670800280774\ \(0\)\
\-\ abdominal\\:\\ 0\\.16014258035563297\ \(0\)\
\-\ and\\:\\ 0\\.15126119327438853\ \(0\)\
\-\ infiltrative\\:\\ 0\\.1500213228723684\ \(0\)\
\-\ notable\\:\\ 0\\.14641329250239873\ \(0\)\
\-\ processes\\:\\ 0\\.14400543774862473\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.1411105457182192\ \(0\)\
\-\ pancreas\\:\\ 0\\.13759806004370012\ \(0\)\
\-\ setting\\:\\ 0\\.1361476763350996\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.12401463975828779\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.11835808053515202\ \(0\)\
\-\ mildly\\:\\ 0\\.1182174502564952\ \(0\)\
\-\ nodular\\:\\ 0\\.11658738113500572\ \(0\)\
\-\ increasing\\:\\ 0\\.11530386560935661\ \(0\)\
\-\ presenting\\:\\ 0\\.11468540287246203\ \(0\)\
\-\ with\\:\\ 0\\.11466958647309038\ \(0\)\
\-\ colon\\:\\ 0\\.11147309560980517\ \(0\)\
\-\ thoracic\\:\\ 0\\.10940221779779663\ \(0\)\
\-\ pattern\\:\\ 0\\.10930293348968605\ \(0\)\
\-\ breast\\:\\ 0\\.106313088510004\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.10596270816519297\ \(0\)\
\-\ palpable\\:\\ 0\\.10285295832827718\ \(0\)\
\-\ labs\\:\\ 0\\.10142884334044588\ \(0\)\
\-\ elevated\\:\\ 0\\.0998043834336307\ \(0\)\
\-\ enlarged\\:\\ 0\\.0998043834336307\ \(0\)\
\-\ examination\\:\\ 0\\.09368349980985759\ \(0\)\
\-\ clinical\\:\\ 0\\.09278288243300425\ \(0\)\
\-\ abdomen\\:\\ 0\\.0893297881812609\ \(0\)\
\-\ lung\\:\\ 0\\.08905819875122235\ \(0\)\
\-\ focal\\:\\ 0\\.08757122638438647\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08719162266095329\ \(0\)\
\-\ of\\:\\ 0\\.08595083425183327\ \(0\)\
\-\ enhancement\\:\\ 0\\.08426660350373366\ \(0\)\
\-\ evidence\\:\\ 0\\.08309815311412766\ \(0\)\
\-\ these\\:\\ 0\\.08267334405049884\ \(0\)\
\-\ metastatic\\:\\ 0\\.08029432662986836\ \(0\)\
\-\ physical\\:\\ 0\\.07938267672838999\ \(0\)\
\-\ consistent\\:\\ 0\\.07938267672838999\ \(0\)\
\-\ other\\:\\ 0\\.0760290541992082\ \(0\)\
\-\ but\\:\\ 0\\.07239615596931487\ \(0\)\
\-\ findings\\:\\ 0\\.07225539714314128\ \(0\)\
\-\ disease\\:\\ 0\\.06145447593824289\ \(0\)\
\-\ history\\:\\ 0\\.05593414608984328\ \(0\)\
\-\ mass\\:\\ 0\\.05592176251341966\ \(0\)\
\-\ are\\:\\ 0\\.05555300672083302\ \(0\)\
\-\ this\\:\\ 0\\.0503064597132605\ \(0\)\
\-\ patient\\:\\ 0\\.047617311949181215\ \(0\)\
\-\ no\\:\\ 0\\.04760835541039201\ \(0\)\
\-\ for\\:\\ 0\\.044373407315171025\ \(0\)\
\-\ on\\:\\ 0\\.04421600135326411\ \(0\)\
\-\ in\\:\\ 0\\.03642013577450314\ \(0\)\
